Recent advances in the treatment of C. difficile using biotherapeutic agents

Clostridium difficile (C. difficile) is rapidly becoming one of the most prevalent health care–associated bacterial infections in the developed world. The emergence of new, more virulent strains has led to greater morbidity and resistance to standard therapies. The bacterium is readily transmitted b...

Descripción completa

Detalles Bibliográficos
Autores principales: Giau, Vo Van, Lee, Hyon, An, Seong Soo A, Hulme, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6579870/
https://www.ncbi.nlm.nih.gov/pubmed/31354309
http://dx.doi.org/10.2147/IDR.S207572

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6579870/
https://www.ncbi.nlm.nih.gov/pubmed/31354309
http://dx.doi.org/10.2147/IDR.S207572

Ejemplares similares